STOXX 600 falls on banks drag; tech contains losses on ASMI boost

Apr 24, 202409:18 UTC

Key points:

Evotec slides after outlook misses expectations
Roche drops on lower Q1 sales
Kering slumps on warning of H1 operating profit drop
Temenos down after Hindenburg allegations impact Q1

Europe's benchmark stock index dropped on Wednesday as financials sagged on disappointing earnings from Swedish lender Handelsbanken, while technology stocks limited losses after ASM International's strong forecast.

The pan-continent STOXX 600 index SXXP closed 0.5% lower after initially rising to its highest in over a week.

Bank shares (.SX7P) lost 1.2% after Handelsbanken SHB_A tumbled 12.1% following a first-quarter net profit miss, while SEB SEB_A shed 3.7% after posting weaker-than-expected interest income in the first quarter.

Financials (.SXFP) led sectoral declines, down 2%, with Allfunds ALLFG losing 11% after a report that the fund manager abandoned talks over a potential sale.

UBS UBSG fell 2.9% after the bank's executives flagged major concerns about the Swiss government's plan to hit it with tougher capital requirements.

Tech stocks <.SX8P> rose 1.3% after ASM International ASM jumped 11% as the wafer-processing equipment supplier raised its second-quarter revenue forecast.

Of the 34 STOXX 600 companies that have reported first-quarter earnings, 61.8% exceeded estimates, compared with a long-term average of 54%, LSEG data on Tuesday showed.

Sentiment soured after Bundesbank President Joachim Nagel noted euro zone inflation could remain stubborn, so a possible interest rate cut by the European Central Bank might not be followed by further policy easing.

"The ECB may potentially cut by 25 basis points in June and then hold for a month or two in order to assess its impact," said Daniela Hathorn, senior market analyst at Capital.com.

"But out of the major central banks, the ECB looks the most likely to cut."

European stocks had a stellar run in the previous two quarters, before pausing in April as geopolitical tensions and concerns around a weak earnings season overshadowed optimism of an imminent rate cut.

Evotec EVT slumped 32% after the German biotech firm announced a disappointing 2024 outlook.

Drugmaker Roche RO lost 3.3% after first-quarter sales slipped 6% on the loss on COVID-related revenue.

Volvo Car VOLCAR_B slumped 10.3% after the Swedish automaker posted downbeat quarterly profits, while Kering KER fell 6.9% after the luxury goods maker forecast a 40% to 45% plunge in first-half operating profit.

Temenos TEMN dropped 8.7% after the Swiss banking software group reported that short seller allegations from February led to delays in client decision-making in the first quarter.